One-step synthesis of Mo(0) and W(0) bis(dinitrogen) complexes with the linear tetraphosphine ligand prP4: stereoselective formation of cis-[M(N2)2(rac-prP4)] and trans-[M(N2)2(meso-prP4)]; M = Mo, W

A new synthetic pathway to Chatt-type Mo(0) and W(0) bis(dinitrogen) complexes with the ligand prP(4) is presented (prP(4) is a linear tetraphos ligand with two ethylene bridges and a central propylene bridge). The synthesis starts from MoCl(5) and WCl(6), respectively, employing Mg as reductant. Whereas the electrochemical reduction of the oxido-iodido-molybdenum(IV) complex [Mo(O)I(meso-prP(4)](+) (1) only gave trans-[Mo(N(2))(2)(meso-prP(4))] (2a; R?mer et al., Eur. J. Inorg. Chem.2008, 3258), the direct synthesis under normal conditions affords both trans and cis complexes 2a and 2b. The reaction products are characterised by vibrational and NMR spectroscopy. Moreover, a single-crystal X-ray structure determination of cis-α-[Mo(N(2))(2)(rac-prP(4))] (2b) is performed. In contrast to the trans bis(dinitrogen)molybdenum(0) complex 2a supported by the meso prP(4) ligand the corresponding cis-complex is exclusively coordinated by the rac isomer of prP(4). The reactivity of 2 with acids is investigated as well, leading to the NNH(2) complex [MoF(NNH(2))(meso-prP(4))]BF(4) (15). Analogous results are obtained with the tungsten complexes.     

Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC5H4N)2(PTA)2], and trans-[Pt(SC5H4N)2(DAPTA)2

A series of gold(I) and platinum(II) complexes of the type [Au(SR)(P)] and trans-[Pt(SR) 2(P) 2] [SR = 2-thiopyridine (SPy), 2-thiopyrimidine (SPyrim); P = 1,3,5-triaza-7-phosphaadamantane (PTA), 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (DAPTA)] were prepared and characterized, and their in vitro cytotoxicities against a panel of seven human cancer cell lines were evaluated. The highly water soluble gold(I) complexes [Au(SR)(P)] [P = PTA and SR = SPy ( 1), SPyrim ( 2); P = DAPTA and SR = SPy ( 3), SPyrim ( 4)] showed low cytotoxicity, while the platinum(II) complexes trans-[Pt(SR) 2(P) 2] [P = PTA and SR = SPyrim ( 5), SPy ( 6); P = DAPTA and SR = SPyrim ( 7), SPy ( 8)] demonstrated potent cytotoxicity for ovarian, colon, renal, and melanoma cancer cell lines on the basis of a comparison with ID 50 values for some established cytotoxic drugs. Single crystals of 2, 5, 6, and 8 suitable for X-ray structural characterization were obtained, and the study revealed the trans configuration for 5, 6, and 8 in their solid states.     

Preparation and properties of dinitrogen complexes of molybdenum and tungsten with trimethylphosphine as coligand : III. Synthesis and properties of cis-[W(N2)2(PMe3)4], trans-[W(C2H4)2(PMe3)4] and [M(N2)(PMe3)5] (M = Mo,W). The crystal and molecular structure of [Mo(N2)(PMe3)5]

The reduction of [WCl₄(PMe₃)₃] with dispersed sodium, under dinitrogen, gives cis-[W(N₂)₂(PMe₃)₄], while under ethylene trans-[W(C₂H₄)₂(PMe₃)₄] is obtained. The ethylene complex can also be prepared by displacement of the dinitrogen molecules in cis-[W(N₂)₂(PMe₃)₄] by ethylene at room temperature and pressure. Interaction of cis-[M(N₂)₂(PMe₃)₄] complexes (M = Mo, W), with PMe₃, under helium or argon, yields [M(N₂)(PMe₃)₅]. The molybdenum complex crystallizes in the orthorhombic space group Pnma, with a 22.063(6), b 12.106(4), c 9.745(4) Å. The Mo—P distance trans to the dinitrogen ligand (2.483(7) Å) is slightly longer than the average of the other four Mo—P bonds (2.460(5) Å).     

The effect of the diphosphine basicity on the excited-state properties of trans-(N2)2W(R2PCH2CH2PR2)2: identification of near-degenerate, luminescent 3MLCT and 3LF terms

Absorption spectra (77 and 298 K), luminescence spectra (5-80 K), and luminescence lifetimes (5-80 K) for the title complexes have been correlated to increasing diphosphine basicity (R = 4-CF(3)-Ph < 4-H-Ph < 4-CH(3)O-Ph < Et). As a consequence, spectral peaks have been assigned to (1,3)MLCT (B(1u), W --> phosphorus) and (1,3)LF (B(2g)) terms. As the ligand basicity increases, the (3)MLCT bands observed in absorption blue-shift nearly 8000 cm(-1) and the vibrationally structured (3)LF bands observed in emission red-shift approximately 1300 cm(-1). (3)LF terms lie lowest in energy in the 4-H-Ph, 4-CH(3)O-Ph, and Et compounds, and temperature-dependent lifetime data suggest emission from each be assigned to the equilibrated, spin-orbit split levels of the (3)LF term. The (3)LF and (3)MLCT excited-state terms lie close in energy in the 4-CF(3)-Ph compound, resulting in an emission band shape that is temperature-dependent. At 77 K, the emission band is broad and structureless and is assigned to arise primarily from the (3)MLCT term. As the temperature is lowered toward 5 K, the (3)MLCT emission diminishes in intensity accompanied by the development of a vibrational structure that is characteristic of emission from the (3)LF term. These excited-state terms satisfy the requirements (different orbital origins, near-degeneracy) for separation by a Franck-Condon energy barrier, resulting in simultaneous emission from both terms between 5 and 77 K.     

Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2

The photodecomposition of the anticancer complex trans,trans,trans-[Pt(N(3))(2)(OH)(2)(NH(3))(2)] in acidic aqueous solution, as well as in phosphate-buffered saline (PBS), induced by UVA light (centred at λ = 365 nm) has been studied by multinuclear NMR spectroscopy. We show that the photoreaction pathway in PBS, which involves azide release, differs from that in acidic aqueous conditions, under which N(2) is a major product. In both cases, a number of trans-{N-Pt(II/IV)-NH(3)} species were also observed as photoproducts, as well as the evolution of O(2) and release of free ammonia with a subsequent increase in pH. The results from this study illustrate that photoinduced reactions of Pt(IV)-diazido derivatives can lead to novel reaction pathways, and therefore potentially to new cytotoxic mechanisms in cancer cells.     

Organometallic oligomers based on 1,8-Diisocyano-p-menthane (dmb): syntheses and characterization of the [[M(diphos)(dmb)]BF4]n and [[Pd2(diphos)2(dmb)](ClO4)2]n materials (M = Cu, Ag; diphos = dppe, dppp)

A new strategy to synthesize organometallic oligomers is presented and consists of using the title diisocyanide and chelated metal fragments with bis(diphenylphosphine)alkanes. The title materials are synthesized by reacting the [M(dppe)(BF4)] and [M2(dppp)2](BF4)2 complexes (M = Cu, Ag; dppe = bis(diphenylphosphino)ethane, dppp = bis(diphenylphosphino)propane) with dmb and the Pd2-bonded d9-d9 Pd2(dmb)2Cl2 dimer with dppe or dppp. The model compounds [M(diphos)(CN-t-Bu)2]BF4 (M = Cu, Ag) and [Pd2(diphos)2(CN-t-Bu)2](ClO4)2 (diphos = dppe, dppp) have been prepared and characterized as well for comparison purposes. Three of the model compounds were also characterized by X-ray crystallography to establish the diphosphine chelating behavior. The materials are amorphous and have been characterized from the measurements of the intrinsic viscosity, DSC, TGA, and XRD, as well as their capacity for making stand-alone films. The intrinsic viscosity data indicate that the Cu and Pd2 materials are oligomeric in solution (approximately 8-9 units), while the Ag materials are smaller. For [[Cu(dppe)(dmb)]BF4]n, a glass transition is reproducibly observed at about 82 degrees C (DeltaCp = 0.43 J/(g deg)), which suggests that these materials are polymeric in the solid state. The Cu and Ag species are luminescent in the solid state at room temperature exhibiting lambda(max) and tau(e) (emission lifetime) around 480-550 nm and 18-48 micros, respectively, while the Pd2 species are not luminescent under these conditions. During the course of this study, the unsaturated [M2(dppp)2](BF4)2 starting materials (M = Cu, Ag) were prepared, one of which (M = Ag) was characterized by crystallography. The bridging behavior of the dppp ligand in this case contrasts with the chelating behavior seen for the saturated [Cu(dppp)(CN-t-Bu)2]BF4 complex.     

Combined theoretical and computational study of interstrand DNA guanine-guanine cross-linking by trans-[Pt(pyridine)2] derived from the photoactivated prodrug trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2

Molecular modeling and extensive experimental studies are used to study DNA distortions induced by binding platinum(II)-containing fragments derived from cisplatin and a new class of photoactive platinum anticancer drugs. The major photoproduct of the novel platinum(IV) prodrug trans,trans,trans-[Pt(N(3))(2)(OH)(2)(py)(2)] (1) contains the trans-{Pt(py)(2)}(2+) moiety. Using a tailored DNA sequence, experimental studies establish the possibility of interstrand binding of trans-{Pt(py)(2)}(2+) (P) to guanine N7 positions on each DNA strand. Ligand field molecular mechanics (LFMM) parameters for Pt-guanine interactions are then derived and validated against a range of experimental structures from the Cambridge Structural Database, published quantum mechanics (QM)/molecular mechanics (MM) structures of model Pt-DNA systems and additional density-functional theory (DFT) studies. Ligand field molecular dynamics (LFMD) simulation protocols are developed and validated using experimentally characterized bifunctional DNA adducts involving both an intra- and an interstrand cross-link of cisplatin. We then turn to the interaction of P with the DNA duplex dodecamer, d(5'-C(1)C(2)T(3)C(4)T(5)C(6)G(7)T(8)C(9)T(10)C(11)C(12)-3')·d(5'-G(13)G(14)A(15)G(16)A(17)C(18)G(19)A(20)G(21)A(22)G(23)G(24)-3') which is known to form a monofunctional adduct with cis-{Pt(NH(3))(2)(py)}. P coordinated to G(7) and G(19) is simulated giving a predicted bend toward the minor groove. This is widened at one end of the platinated site and deepened at the opposite end, while the P-DNA complex exhibits a global bend of ～67° and an unwinding of ～20°. Such cross-links offer possibilities for specific protein-DNA interactions and suggest possible mechanisms to explain the high potency of this photoactivated complex.     

Transformation of organic molecules on the low-valent [M(Ph(2)PCH(2)CH(2)PPh(2))(2)] moiety derived from trans-[M(N(2))(2)(Ph(2)PCH(2)CH(2)PPh(2))(2)] or related complexes (M = Mo, W)

A zero-valent [M(Ph(2)PCH(2)CH(2)PPh(2))(2)] moiety (M = Mo, W) generated in situ by dissociation of the N(2) ligands in trans-[M(N(2))(2)(Ph(2)PCH(2)CH(2)PPh(2))(2)] can activate pi-accepting organic molecules including isocyanides and nitriles, which undergo the electrophilic attack caused by a strong pi-donation from a zero-valent metal center. Cleavage of a variety of C-X bonds (X = H, C, N, O, P, halogen) also occurs at their electron-rich sites through oxidative addition to form reactive intermediates, which subsequently degradate to yield smaller molecules either bound to or dissociated from the metal center. The mechanism is substantiated unambiguously by isolation of numerous intermediate stages.     

Chain photosolvation of trans,trans,trans-[PtIV(py)2(N3)2(OH)2] complex prospective as a light-activated antitumor agent

The photochemistry of a potential light-activated anticancer complex, trans,trans,trans-[Pt^IV(py)₂(N₃)₂(OH)₂], was explored by steady-state and laser flash photolysis. The photolysis was a multistage process with the formation of complexes trans-[Pt^IV(py)₂(N₃)(OH)₂(H₂O)]+ and/or trans-[Pt^IV(py)₂(N₃)(OH)₃] due to chain photoaquation at the first stage.     

Synthesis, Structure, Characterization and Electrochemistry of a New Dinuclear W(0)-complex [Et4N]2[W2(CO)8(SCH2COOMe)2]

Reaction of Et4NCl, NaSCH2COOMe and W(CO)6 in MeCN affords a new dinuclear tungsten(0) complex [Et4N]2[W2(CO)8(SCH2COOMe)2] (1). The crystal and molecular structure has been determined by X-ray single crystal diffraction. 1 Crystallized in the triclinic, space group P with a=11.141(7), b=10.267(4), c=10.798(3)(); α=93.96(3), β=96.88(4), γ=114.97(5)°; V=1003()3, Z=1, Dc=1.76 g/cm3, μ=60.1 cm-1, R=0.042 and Rw=0.050 for 2967 independent reflections with I>3.0 σ(I). 1 contains a WS2W planar core with nonbonding W...W distance of 3.9611(5)(), and its IR, 13C NMR, and cyclic voltammetry were measured and discussed.     

Synthesis of the cyanamide-derived bis(cyanoimido) complexes trans-[M(NCN)2(Ph2PCH2CH2PPh2)2] (M = Mo or W) and crystal structure of the molybdenum compound

Reaction of cyanamide (NCNH₂) with trans-[M(N₂)₂(dppe)₂] (M = Mo or W, dppe = PH₂PCH₂CH₂PPh₂) leads to the formation of the bis(cyanoimido) complexes trans-[M(NCN)₂(dppe)₂]. The crystal structure of trans-[Mo(NCN)₂(dppe)₂] has been determined by an X-ray diffraction study.     

Studies on the alcohol exchange reactions of methoxide ditungsten [W(IV)] compound W2Cl4(OCH3)4 (CH3OH)2, prepared from (n-Bu4N)3W2Cl9

(n-Bu₄N)₃W₂Cl₉, prepared from K₃W₂Cl₉, can be readily converted to a series of [W(IV)] cluster compounds, W₂Cl₄ (μ-OR)₂ (OR')₂ (R'OH)₂, including seven known compounds and two new compounds with R=Me, R'=i-Pr and sec-Bu. The crystallographic data of 7 and 8 are hereby presented.     

N1 and N3 linkage isomers of neutral and deprotonated cytosine with trans-[(CH3NH2)2PtII

A series of complexes obtained from the reaction of trans-[(CH3NH2)2PtII] with unsubstituted cytosine (CH) and its anion (C), respectively, has been prepared and isolated or detected in solution: trans-[Pt(CH3NH2)2(CH-N3)Cl]Cl.H2O (1), trans-[Pt(CH3NH2)2(CH-N3)2](ClO4)2 (1a), trans-[Pt(CH3NH2)2(C-N3)2].2H2O (1b), trans-[Pt(CH3NH2)2(CH-N3)2](ClO4)(2).2DMSO (1c), trans-[Pt(CH3NH2)2(CH-N1)2] (NO3)(2).3H2O (2a), trans-[Pt(CH3NH2)2(C-N1)2].2H2O (2b), trans-[Pt(CH3NH2)2(CH-N1)(CH-N3)](ClO4)2 (3a), trans-[Pt(CH3NH2)2(C-N1)(C-N3)] (3b), and trans-[Pt(CH3NH2)2(N1-CN3)(N3-C-N1)Cu(OH)]ClO(4).1.2H2O (4). X-ray crystal structures of all these compounds, except 3a and 3b, are reported. Complex 2a is of particular interest in that it contains the rarer of the two 2-oxo-4-amino tautomer forms of cytosine, namely that with the N3 position protonated. Since the effect of PtII on the geometry of the nucleobase is minimal, bond lengths and angles of CH in 2a reflect, to a first approximation, those of the free rare tautomer. Compared to the preferred 2-oxo-4-amino tautomer (N1 site protonated) of CH, the rare tautomer in 2a differs particularly in internal ring angles (7-11 sigma). Formation of compounds containing the rare CH tautomers on a preparative scale can be achieved by a detour (reaction of PtII with the cytosine anion, followed by cytosine reprotonation) or by linkage isomerization (N3-->N1) under alkaline reaction conditions. Surprisingly, in water and over a wide pH range, N1 linkage isomers (3a, 2a) form in considerably higher amounts than can be expected on the basis of the tautomer equilibrium. This is particularly true for the pH range in which the cytosine is present as a neutral species and implies that complexation of the minor tautomer is considerably promoted. Deprotonation of the rare CH tautomers in 2a occurs with pKa values of 6.07 +/- 0.18 (1 sigma) and 7.09 +/- 0.11 (1 sigma). This value compares with pKa 9.06 +/- 0.09 (1 sigma) (average of both ligands) in 1a.